Profile
Ron Ellis is currently a Director at GeneQuine Biotherapeutics GmbH and CarthroniX, Inc. He was formerly a Chief Strategy Officer at Pacira Biosciences, Inc. Dr. Ellis holds an MBA from St. Joseph's University and a doctorate from Philadelphia College of Osteopathic Medicine.
Ron Ellis active positions
| Companies | Position | Start |
|---|---|---|
GeneQuine Biotherapeutics GmbH
GeneQuine Biotherapeutics GmbH Pharmaceuticals: MajorHealth Technology Develops transformative treatments for chronic, prevalent conditions such as osteoarthritis and intervertebral disc degeneration | Director/Board Member | - |
CarthroniX, Inc.
CarthroniX, Inc. Medical/Nursing ServicesHealth Services Provides wound healing, small molecule based therapy skin regeneration, and novel solutions | Director/Board Member | - |
Former positions of Ron Ellis
| Companies | Position | End |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Training of Ron Ellis
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Pacira Biosciences, Inc.
Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
St. Joseph's University
St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Philadelphia College of Osteopathic Medicine
Philadelphia College of Osteopathic Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GeneQuine Biotherapeutics GmbH
GeneQuine Biotherapeutics GmbH Pharmaceuticals: MajorHealth Technology Develops transformative treatments for chronic, prevalent conditions such as osteoarthritis and intervertebral disc degeneration | Health Technology |
CarthroniX, Inc.
CarthroniX, Inc. Medical/Nursing ServicesHealth Services Provides wound healing, small molecule based therapy skin regeneration, and novel solutions | Health Services |
- Stock Market
- Insiders
- Ron Ellis
















